The #1 dermatologist-recommended skincare brand in the US. Trust is built on "Developed with Dermatologists" and a ceramide-forward barrier-repair story. Navigation is concern-driven (acne, eczema, dry skin), then filtered by product type and ingredient. The "Skin Smarts" education hub converts browsing into buying.
Radical ingredient transparency. Products are named after their formulas ("Niacinamide 10% + Zinc 1%"). The Regimen Builder is a 7+ question quiz that outputs AM/PM routines with one-click basket add. Site navigation is by category and Targeted Solutions — the Prep → Treat → Seal model is the regimen framework, not the nav.
French pharmaceutical heritage, Vichy.eg localizes for Egypt. SkinConsult AI is a selfie-driven tool that grades 7 signs of aging against a 10,000+ image database — specifically an aging analysis, not a general concern diagnosis. Ranges (MINERAL 89, NORMADERM) operate as sub-brands within a deep mega-menu.
The closest direct model for skncel — a pharmaceutical sub-brand with its own page system under a parent. Effaclar's anti-blemish 3-step is Cleanse → Tone/Exfoliate → Treat (with Duo+M). Clinical % claims carry the page ("up to 60% acne reduction in 10 days"; "9/10 dermatologists recommend"). Kits are sold as complete routines, not loose SKUs.
All four brands let users enter the catalog by skin concern (acne, dryness, sensitivity) before product type. This is the highest-converting entry model for pharma-skincare.
Effaclar's anti-blemish kit is Cleanse → Tone/Exfoliate → Treat. The Ordinary's regimen model is Prep → Treat → Seal. CeraVe's AM routine is Cleanse → Treat → Moisturize/SPF. skncel should pick one framing and own it — don't conflate.
Effaclar leads with outcome claims ("up to 60% acne reduction in 10 days", "3× less breakouts"). These convert better than feature lists for pharma-adjacent skincare.
Every brand dedicates PDP real estate to key actives with scientific explanations. Builds credibility with the research-driven buyer.
Direct quotes from board-certified dermatologists, co-development claims, "derm-tested" and "dermatologist-recommended" badges. Essential for pharmaceutical credibility.
Vichy's SkinConsult AI is best-in-class but aging-specific. For skncel's concern-driven positioning (acne, oily, sensitive, hyperpigmentation), a question-led tool beats a photo-led one — and costs a fraction to build.
CeraVe's "Skin Smarts" and La Roche-Posay's editorial content link directly to PDPs from articles. Drives organic SEO and moves users from learn → buy.
Effaclar's dedicated page shows the complete range in context, with filterable grid, routine builder at top, and education below. The template for skncel.
La Roche-Posay shows "Select a size" inline on product cards, reducing nav depth and accelerating purchase decisions.
Effaclar uses split-view clinical photography. Expected and trusted in pharma-skincare — its absence signals lower efficacy to the target audience.
Product attribute badges (non-comedogenic, fragrance-free, paraben-free) visible on cards. The pharma audience needs these upfront, not buried in ingredients.
The Ordinary uses a sticky cart sidebar. For routine-building, "Add routine" alongside "Add to cart" reduces friction for multi-product purchases.
All sub-brands display parent affiliation. For skncel, "A Parkville formula" in the header adds instant pharma credibility — arguably the single highest-leverage trust signal for a new brand.
Product detail pages show numbered, illustrated application steps. Reduces returns, increases satisfaction, and demonstrates product expertise.
All brands prominently support regional switching. For skncel in Egypt/MENA, Arabic RTL and local pricing are table stakes — see design direction for the RTL-first commitment.
Star ratings and verified buyer reviews on cards and PDPs. Pharma-skincare customers are review-dependent before first purchase.
The Ordinary's birthday sale and CeraVe's sweepstakes show that even clinical brands use urgency triggers. Strategic use won't compromise authority.
Every brand surfaces complementary products below PDPs. For a narrow product line (skncel at launch), a routine cross-sell block maximizes basket size from day one.
skncel's defensible wedge isn't "clinical transparency" — that's the category's table stakes, claimed by every reference brand. The actual wedge is three things the references can't easily copy, all specific to skncel's position in this market.
A named pharmaceutical parent with real in-market credibility. CeraVe has L'Oréal behind it but rarely surfaces it; skncel should surface Parkville constantly.
Concerns under-served by US/EU-centric brands: post-inflammatory hyperpigmentation in Fitzpatrick III–V skin, humidity-driven acne, high-intensity UV, melasma.
RTL layouts, typography, and content designed in parallel from day one — not retrofitted. No direct competitor in this price tier does this properly.
Precise but human. Scientific without intimidating. Skincare as self-care grounded in pharmaceutical research — not vanity, not cold medicine.
Between CeraVe's functional clinical feel and The Ordinary's austerity. More elevated than drugstore, more approachable than laboratory.
The references don't agree on a single 3-step model. Effaclar's anti-blemish kit is Cleanse → Tone/Exfoliate → Treat. The Ordinary's regimen model is Prep → Treat → Seal. CeraVe's AM routine is Cleanse → Treat → Moisturize/SPF. skncel's proposed framing is Cleanse → Treat → Protect — active treatment in the middle, SPF as non-negotiable third. This is deliberately synthesized for a narrow product line launching in a high-UV market.
A restrained palette anchored by a pharmaceutical teal-green, with near-white backgrounds and deep charcoal text. Warm sand accents for human warmth.
Concern-based, not selfie-based. Questions: skin type → primary concern → severity → secondary concerns → sensitivity → routine experience → (optional) age range → goals. Outputs a 2–3 product routine with "add all to cart." Deeper than a 4-question micro-form, lighter than Vichy's full AI.
Every collection page opens with skncel's 3-step visual (Cleanse → Treat → Protect). Users see where each product fits before browsing the full grid. Products can be swapped within step.
Tap any ingredient badge on a PDP to open a modal: what it does, how it's sourced, what concentration is used, what it conflicts with. Borrowed from The Ordinary's formula-first ethos.
A subtle persistent header element linking skncel to Parkville's pharma credentials. Tap opens a brand story overlay. The primary differentiator from DTC beauty brands.
The design system is identical for both options. The difference is scope, timeline, technical constraints, brand control, and — crucially — which flagship features are actually buildable in Phase 1.
skncel gets a dedicated section within Parkville's current platform. Our deliverable is a design specification package — hi-fi screens, component specs, and a dev handoff doc for the Parkville team.
skncel gets its own domain and brand identity. Full creative control. The deliverable is a design system and a production-ready platform with every feature built for the brand, not inherited.
Option 1's constraint is real: a shared platform limits bespoke UX. This table makes the trade-off explicit so nobody is surprised later.
| Feature | Option 1 (Parkville) | Option 2 (standalone) |
|---|---|---|
| Concern-first navigation | Ships | Ships |
| 3-step routine anchor | Static | Dynamic, personalized |
| PDP with clinical % claims | Ships | Ships |
| Ingredient transparency modal | If Parkville CMS supports | Ships |
| "A Parkville formula" trust ribbon | Ships | Ships |
| Verified reviews + attribute badges | Inherited from Parkville | Bespoke build |
| Skin profile quiz (6–8 questions) | Phase 2 — deferred | Core feature |
| Personalized routine engine | Phase 2 — deferred | Core feature |
| Account-level skin profile | Uses Parkville accounts | Bespoke profile schema |
| Education hub | Article templates only | Full hub with product links |
| Arabic RTL | Design-ready | Full build parity |
Start with Option 1 as a market-validation phase — ship the skncel brand experience inside Parkville's platform with the features that the table above marks as ships or partial. This tests product-market fit without full platform investment. Design the system so that the features marked "Phase 2 — deferred" (the interactive quiz and personalization engine) drop in naturally the moment skncel moves to Option 2. The design deliverables we produce now are valid for both scenarios.
Schematic mockups showing layout logic, hierarchy, and component placement for each key page. Desktop is shown; mobile variants follow the same hierarchy in single column with condensed nav.
Pricing reflects the scope and governance required to deliver pharma-grade UX, accounting for Arabic RTL parity and clinical content review. All figures in EGP, exclusive of VAT. Offer valid for 30 days.
Strategy, design and build delivered end-to-end by our studio. Specialist partners engaged where scope requires.
If skncel commits to Option 2 within 90 days of Option 1 completion, the full 120,000 EGP design fee is credited against the Option 2 total. Net upgrade investment: 330,000 EGP. This makes Option 1 a genuine validation phase, not a sunk cost.
| Milestone | Option 1 (120,000 EGP) | Option 2 (450,000 EGP) |
|---|---|---|
| On signature (kickoff) | 40% — 48,000 | 30% — 135,000 |
| Design sign-off | 30% — 36,000 | 25% — 112,500 |
| Build / staging sign-off | — | 25% — 112,500 |
| Final handoff / go-live | 30% — 36,000 | 20% — 90,000 |
| Add-on | Fee | Notes |
|---|---|---|
| Product photography direction | 38,000 EGP | Shot list, styling brief, photographer management. Photographer fees pass-through. |
| Education content package | 52,000 EGP | 5 articles (EN + AR), MENA-skin focus, derm-reviewed where claims require it. |
| Analytics & tracking setup | 22,000 EGP | GA4, Meta Pixel, conversion events, GTM configuration. |
| Extended RTL QA round | 18,000 EGP | Native-Arabic-speaker review of typography, line-breaks, translation fit. |
Begin with Option 1 as validation. Design the full skncel experience, ship it inside Parkville's platform with the features marked "ships" or "partial" in the Platform Options tab. Test product-market fit with real traffic for 60–90 days. If the brand proves out, trigger Option 2 upgrade within the 90-day credit window — the design work is already done, and 450,000 EGP additional investment activates the standalone platform with the deferred flagship features (quiz, personalized routine engine, full education hub, RTL parity build).
Sign-off on this offer triggers kickoff within 5 business days. Initial invoice for 40% (Option 1) or 30% (Option 2) issued on signature. First working session scheduled in week 1 to lock quiz content strategy and Arabic type pairing — the two open decisions from the design direction phase.